Results from dose-escalation study show safety and preliminary efficacy signal of NGGT001 for the treatment of BCD WALNUT CREEK, Calif., Jan. 14, 2025 /PRNewswire/ — NGGT Inc., (“Next Generation Gene Therapeutics” or “NGGT” or the “Company”), a clinical-stage biotechnology company…
